Vanguard Trims BioLife Solutions Stake to 8.9%

TL;DR

**Vanguard cut its BioLife Solutions stake to 8.9%, watch for other institutional moves.**

AI Summary

The Vanguard Group, a major investment firm, filed an amended SC 13G/A on February 13, 2024, disclosing its ownership of 3,747,381 shares of BioLife Solutions Inc. common stock as of December 29, 2023. This represents 8.9% of BioLife Solutions' outstanding shares, a slight decrease from their previous filing. This matters to investors because Vanguard is a significant institutional holder, and changes in their position can signal their confidence (or lack thereof) in the company's future prospects.

Why It Matters

Vanguard's slight reduction in its stake could indicate a minor shift in its investment strategy or outlook for BioLife Solutions, which might influence other investors.

Risk Assessment

Risk Level: low — This filing indicates a minor adjustment by a large institutional investor, not a drastic change that would significantly impact the company's fundamentals.

Analyst Insight

Investors should note Vanguard's slight reduction in stake but recognize that it still maintains a substantial position, indicating continued, albeit slightly tempered, confidence in BioLife Solutions. This might prompt a deeper dive into BioLife Solutions' recent performance and future outlook.

Key Numbers

• 3,747,381 — Shares Beneficially Owned (Represents the total number of BioLife Solutions common stock shares Vanguard holds.)
• 8.9% — Percentage of Class (Indicates Vanguard's significant ownership stake in BioLife Solutions.)
• December 29, 2023 — Event Date (The specific date when Vanguard's ownership position triggered the need for this filing.)

Key Players & Entities

• The Vanguard Group (company) — reporting person and institutional investor
• BioLife Solutions Inc. (company) — subject company whose securities are being reported
• 3,747,381 shares (dollar_amount) — total shares of common stock beneficially owned by Vanguard
• 8.9% (dollar_amount) — percentage of BioLife Solutions' class of securities owned by Vanguard
• December 29, 2023 (date) — date of the event requiring the filing
• February 13, 2024 (date) — filing date of the SC 13G/A amendment

Forward-Looking Statements

• Vanguard will continue to be a significant institutional holder of BioLife Solutions stock. (The Vanguard Group) — high confidence, target: Next 12 months

FAQ

Filing Documents

• tv0436-biolifesolutionsinc.htm (SC 13G/A) — 11KB
• 0001104659-24-020433.txt ( ) — 13KB

(a) - Name of Issuer

Item 1(a) - Name of Issuer: BioLife Solutions Inc

(b) - Address of Issuer's Principal Executive Offices

Item 1(b) - Address of Issuer's Principal Executive Offices: 3303 Monte Villa Parkway, Suite 310 Bothell, WA 98021

(a) - Name of Person Filing

Item 2(a) - Name of Person Filing: The Vanguard Group - 23-1945930

(b) – Address of Principal Business Office or, if none, residence

Item 2(b) – Address of Principal Business Office or, if none, residence: 100 Vanguard Blvd. Malvern, PA 19355

(c) – Citizenship

Item 2(c) – Citizenship: Pennsylvania

(d) - Title of Class of Securities

Item 2(d) - Title of Class of Securities: Common Stock

(e) - CUSIP Number

Item 2(e) - CUSIP Number 09062W204

- Type of Filing

Item 3 - Type of Filing: This statement is being filed pursuant to Rule 13d-1. An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E).

- Ownership

Item 4 - Ownership: (a) Amount Beneficially Owned: (b) Percent of Class: (c) Number of shares as to which such person has: (i) sole power to vote or direct to vote: (ii) shared power to vote or direct to vote: (iii) sole power to dispose of or to direct the disposition of: (iv) shared power to dispose or to direct the disposition of: Comments: The responses to questions 5 through 9 and 11 on the cover page(s) are incorporated by reference into this Item 4.

- Ownership of Five Percent or Less of a Class

Item 5 - Ownership of Five Percent or Less of a Class: If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following

- Ownership of More Than Five Percent on Behalf of Another Person

Item 6 - Ownership of More Than Five Percent on Behalf of Another Person: The Vanguard Group, Inc.'s clients, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein. No one other person's interest in the securities reported herein is more than 5%. Item 7 - Identification and Classification of the Subsidiary Which Acquired The Security Being Reported on by the Parent Holding Company: Not applicable

- Identification and Classification of Members of Group

Item 8 - Identification and Classification of Members of Group: Not applicable

- Notice of Dissolution of Group

Item 9 - Notice of Dissolution of Group: Not applicable

- Certification

Item 10 - Certification: By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11. Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: February 13, 2024 By /s/ Ashley Grim Name: Ashley Grim Title: Head of Global Fund Administration

View Full Filing

View this SC 13G/A filing on SEC EDGAR